Michele R. Aizenberg, M.D.

Michele R. Aizenberg, M.D.

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine.

Utilizing special imaging and surgical techniques, Dr. Aizenberg is able to resect tumors in eloquent areas of the brain in ways to help prevent neurologic deficits. By individualized care, the best approach is determined for each patient so that they have maximal outcome. She works closely with radiation oncologists, neuro-oncologists, oncologists, neuroradiologists, neuropathologists, and neuropsychologists to provide the most comprehensive care for oncology patients. With this multi-disciplinary approach, comprehensive Neuro-Oncology care can be provided for patients with central nervous system tumors. With this in mind, Dr. Aizenberg was instrumental in establishing the Brain and Spine Cancer Center (BASCC) at the Nebraska Medical Center. In 2009, she was named the Director of the BASCC. For more information, please visit www.nebraskamed.com/cancer/brain-spine.

Credentials:
Bachelor of Science, University of California, Davis
Medical Degree, St. George’s University
Internship, Brown University, Providence, Rhode Island
Residency, George Washington University, Washington, D.C.
Fellowship, Surgical Neurology Branch, NINDS, NIH
Fellowship, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Membership:
American Association of Neurological Surgeons, AANS/CNS Section on Tumors, Congress of Neurological Surgeons, Society for Neuro-Oncology, International Brain Mapping & Intraoperative Surgical Planning Society (IBMISPS)

Brain and Spine Cancer Center

Dr. Aizenberg and many of our specialists are very involved in research to find new treatments and cures for neurological disease. Cooperative and Investigator Initiated Clinical Trials, meaning we aren't just taking part in clinical tries going on in other locations, but we initiate them. To learn more and support our research projects visit the links here:

The Brain Cancer Research Fund - Gifts to this fund allow us to start pilot projects, conduct cross-disciplinary research, fund post-doctoral students participating in studies, host applicable lectures or attend meetings for the collaboration and advancement of novel ideas in the pursuit of improving brain tumor treatments and outcomes.

The Brain and Spine Cancer Research Fund - Gifts to this fund affords our doctors the opportunity to take part in some of the most current clinical trials, giving patients early access to the newest drugs and most leading-edge treatment options before they become widely available.